... improve access to care and push pharmaceutical companies, insurance providers and biotech companies to ensure patients can afford treatments.
News
- Biden outlines steps to pursue post-Obama 'cancer moonshot'
- Lawsuit disputes claims of popular memory-loss supplement
Schneiderman said Quincy Bioscience based its claims primarily on a single study that failed to show a statistically significant improvement in memory.
- There's something missing from one of the largest healthcare investor meetings of the year
In pharma and biotech, the number of women in leadership roles is still fairly low. In September 2015, GSK announced that Emma Walmsley would ...
- The biggest healthcare investor conference is happening next week — here are the 5 things we ...
When they see something that's cool, they all jump on it and say I gotta have it," Doug MacDougall, managing partner at MacDougall Biomedical ...
- Tight labor market hinders search for skilled workers
An encouraging sign, Abair said, was a 57 percent increase in the number of graduates with biotechnology degrees from four-year institutions in ...